EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Gastrointestinal Stromal Tumors
Related studies linked through entity extraction aliases.
The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib
- Status
- COMPLETED
- Phase
- PHASE4
Laparoscopic Resection of Large Gastric Stromal Tumors
- Status
- COMPLETED
- Phase
- N/A
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib
- Status
- COMPLETED
- Phase
- PHASE2
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)
- Status
- TERMINATED
- Phase
- N/A
CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)
- Status
- WITHDRAWN
- Phase
- PHASE2
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors
- Status
- TERMINATED
- Phase
- PHASE2
The Oncopanel Pilot (TOP) Study
- Status
- COMPLETED
- Phase
- N/A
Integrated Cancer Repository for Cancer Research
- Status
- RECRUITING
- Phase
- N/A
Regorafenib Post-marketing Surveillance in Japan
- Status
- COMPLETED
- Phase
- N/A
Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
- Status
- COMPLETED
- Phase
- PHASE3
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2